Stock listing
KRX:389470 Inventage Lab, Inc. (인벤티지랩) 주가
Follow Inventage Lab, Inc. into a list and get an email when it puts out news.
Share price · KRX:389470
₩18,690 KRW -550 (-2.9%)
Close on Nov 20, 2026
- Day range
- ₩18,590 – ₩19,490 KRWNov 20, 2026
- Volume
- 27,254 sharesNov 20, 2026
- Market cap
- ₩248.7B KRWAt the close on Nov 20, 2026 · price × 13.31M shares outstanding
- 52-week range
- ₩18,100 – ₩101,700 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.98B KRWMedian day 53,892 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:389470 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩18,690 | -550 | -2.9% | ₩18,810 | ₩19,490 | ₩18,590 | 27,254 | |
| ₩19,240 | +1,040 | +5.7% | ₩18,400 | ₩19,450 | ₩18,310 | 47,339 | |
| ₩18,200 | -730 | -3.9% | ₩18,400 | ₩18,600 | ₩18,100 | 38,545 | |
| ₩18,930 | -1,270 | -6.3% | ₩20,400 | ₩20,400 | ₩18,670 | 45,056 | |
| ₩20,200 | -450 | -2.2% | ₩20,600 | ₩22,000 | ₩20,050 | 50,988 | |
| ₩20,650 | -1,000 | -4.6% | ₩21,400 | ₩21,800 | ₩20,400 | 73,252 | |
| ₩21,650 | +750 | +3.6% | ₩20,400 | ₩22,050 | ₩20,400 | 37,879 | |
| ₩20,900 | +1,150 | +5.8% | ₩20,000 | ₩21,000 | ₩19,970 | 39,533 | |
| ₩19,750 | +200 | +1.0% | ₩19,650 | ₩20,500 | ₩19,160 | 46,345 | |
| ₩19,550 | -1,700 | -8.0% | ₩19,580 | ₩20,550 | ₩19,330 | 60,825 | |
| ₩21,250 | -750 | -3.4% | ₩22,850 | ₩23,700 | ₩21,250 | 53,561 | |
| ₩22,000 | +100 | +0.5% | ₩22,200 | ₩22,200 | ₩20,400 | 54,351 | |
| ₩21,900 | -850 | -3.7% | ₩22,600 | ₩22,850 | ₩21,700 | 45,304 | |
| ₩22,750 | +650 | +2.9% | ₩21,500 | ₩23,900 | ₩21,500 | 47,656 | |
| ₩22,100 | -900 | -3.9% | ₩22,800 | ₩22,800 | ₩21,800 | 49,176 | |
| ₩23,000 | -950 | -4.0% | ₩23,750 | ₩23,850 | ₩22,650 | 63,495 | |
| ₩23,950 | +1,150 | +5.0% | ₩22,950 | ₩25,150 | ₩22,950 | 70,236 | |
| ₩22,800 | -50 | -0.2% | ₩23,350 | ₩24,450 | ₩22,750 | 44,220 | |
| ₩22,850 | -1,500 | -6.2% | ₩24,000 | ₩24,050 | ₩22,850 | 43,714 | |
| ₩24,350 | -750 | -3.0% | ₩24,300 | ₩24,400 | ₩23,300 | 50,913 | |
| ₩25,100 | -1,100 | -4.2% | ₩25,800 | ₩27,150 | ₩25,000 | 81,872 | |
| ₩26,200 | +1,100 | +4.4% | ₩25,800 | ₩27,500 | ₩25,550 | 96,845 | |
| ₩25,100 | -50 | -0.2% | ₩25,450 | ₩25,950 | ₩24,100 | 54,265 | |
| ₩25,150 | +400 | +1.6% | ₩23,650 | ₩25,300 | ₩23,500 | 41,870 | |
| ₩24,750 | +600 | +2.5% | ₩24,400 | ₩25,600 | ₩23,850 | 148,545 | |
| ₩24,150 | -2,550 | -9.6% | ₩24,650 | ₩25,850 | ₩23,650 | 88,942 | |
| ₩26,700 | +3,350 | +14.3% | ₩23,400 | ₩27,900 | ₩23,150 | 141,390 | |
| ₩23,350 | -1,200 | -4.9% | ₩25,400 | ₩25,400 | ₩22,550 | 124,245 | |
| ₩24,550 | -2,050 | -7.7% | ₩26,700 | ₩27,000 | ₩24,250 | 48,248 | |
| ₩26,600 | -3,350 | -11.2% | ₩29,250 | ₩29,250 | ₩26,600 | 141,934 | |
| ₩29,950 | +2,250 | +8.1% | ₩27,900 | ₩34,000 | ₩27,600 | 402,634 | |
| ₩27,700 | -600 | -2.1% | ₩27,550 | ₩28,600 | ₩26,750 | 97,974 | |
| ₩28,300 | -900 | -3.1% | ₩28,800 | ₩30,400 | ₩28,200 | 106,626 | |
| ₩29,200 | +3,400 | +13.2% | ₩25,250 | ₩29,450 | ₩25,100 | 204,512 | |
| ₩25,800 | +2,050 | +8.6% | ₩23,700 | ₩26,450 | ₩23,500 | 149,288 | |
| ₩23,750 | -150 | -0.6% | ₩25,400 | ₩25,600 | ₩23,600 | 127,336 | |
| ₩23,900 | -600 | -2.4% | ₩25,000 | ₩25,450 | ₩23,700 | 61,841 | |
| ₩24,500 | -500 | -2.0% | ₩25,150 | ₩25,300 | ₩24,450 | 45,287 | |
| ₩25,000 | -650 | -2.5% | ₩25,700 | ₩25,700 | ₩24,950 | 75,412 | |
| ₩25,650 | +200 | +0.8% | ₩31,050 | ₩31,050 | ₩25,550 | 369,080 | |
| ₩25,450 | -600 | -2.3% | ₩25,950 | ₩26,600 | ₩24,800 | 90,327 | |
| ₩26,050 | +1,550 | +6.3% | ₩24,300 | ₩26,100 | ₩24,300 | 68,058 | |
| ₩24,500 | -750 | -3.0% | ₩25,250 | ₩25,250 | ₩23,800 | 84,400 | |
| ₩25,250 | +300 | +1.2% | ₩25,000 | ₩26,000 | ₩24,650 | 123,477 | |
| ₩24,950 | -350 | -1.4% | ₩24,950 | ₩26,100 | ₩24,250 | 59,306 | |
| ₩25,300 | -150 | -0.6% | ₩24,400 | ₩25,750 | ₩24,400 | 54,222 | |
| ₩25,450 | -100 | -0.4% | ₩24,900 | ₩25,450 | ₩24,550 | 55,395 | |
| ₩25,550 | -200 | -0.8% | ₩25,750 | ₩25,900 | ₩25,200 | 41,084 | |
| ₩25,750 | -450 | -1.7% | ₩26,550 | ₩26,700 | ₩25,750 | 38,938 | |
| ₩26,200 | -600 | -2.2% | ₩26,750 | ₩27,700 | ₩26,100 | 36,281 | |
| ₩26,800 | +850 | +3.3% | ₩26,700 | ₩27,150 | ₩25,500 | 45,404 | |
| ₩25,950 | -1,550 | -5.6% | ₩27,850 | ₩27,850 | ₩25,475 | 46,502 | |
| ₩27,500 | -2,000 | -6.8% | ₩30,200 | ₩30,300 | ₩27,500 | 68,216 | |
| ₩29,500 | +1,150 | +4.1% | ₩28,850 | ₩29,700 | ₩28,250 | 31,895 | |
| ₩28,350 | -700 | -2.4% | ₩28,650 | ₩28,900 | ₩27,550 | 33,582 | |
| ₩29,050 | -150 | -0.5% | ₩29,650 | ₩29,800 | ₩28,100 | 35,582 | |
| ₩29,200 | -750 | -2.5% | ₩29,850 | ₩30,350 | ₩28,950 | 45,074 | |
| ₩29,950 | +250 | +0.8% | ₩30,650 | ₩30,850 | ₩29,000 | 32,508 | |
| ₩29,700 | -200 | -0.7% | ₩29,500 | ₩29,850 | ₩27,900 | 39,615 | |
| ₩29,900 | +1,450 | +5.1% | ₩29,000 | ₩30,700 | ₩28,600 | 53,239 | |
| ₩28,450 | -1,800 | -6.0% | ₩29,200 | ₩29,300 | ₩27,800 | 46,835 | |
| ₩30,250 | +150 | +0.5% | ₩33,500 | ₩33,550 | ₩29,950 | 83,623 |
- Ticker
- KRX:389470
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Inventage Lab, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 61.3× against a median of 37.6×: 5th lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩151.5B KRW
- P/E
- Loss
- EV/sales
- 61.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.8×
- Gross margin
- −179.0%
- Operating margin
- Revenue too small
- Net margin
- −127.0%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Inventage Lab, Inc. · KRX:389470 | US$185.9M | US$113.3M | n/a | 61.3× | n/a | 2.8× | −127.0% | 0.2× | n/a |
| SillaJen, Inc. · KRX:215600 | US$193.5M | US$141.7M | n/a | 17.6× | n/a | 2.6× | −223.8% | 0.0× | n/a |
| AN2 Therapeutics, Inc. · NASDAQ:ANTX | US$192.8M | US$128.4M | n/a | n/a | n/a | 2.5× | n/a | 0.0× | 0.54 |
| Cartesian Therapeutics, Inc. · NASDAQ:RNAC | US$187.3M | US$114.5M | n/a | 112× | n/a | n/a | n/a | n/a | 1.23 |
| Artiva Biotherapeutics, Inc. · NASDAQ:ARTV | US$186.9M | −US$123.1M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | 1.34 |
| Inhibikase Therapeutics, Inc. · NASDAQ:IKT | US$185.2M | −US$8.17M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | 1.50 |
| Antengene Corporation Limited · HKEX:6996 | US$183.1M | US$107.1M | n/a | 6.8× | n/a | 1.3× | −227.0% | 0.3× | n/a |
| Whitehawk Therapeutics, Inc. · NASDAQ:WHWK | US$181.2M | US$11.70M | n/a | n/a | n/a | 1.1× | n/a | 0.0× | 1.35 |
| Sol-Gel Technologies Ltd. · NASDAQ:SLGL | US$180.6M | US$137.0M | n/a | 95.4× | n/a | 4.2× | n/a | 0.0× | 0.67 |
| Tanvex BioPharma, Inc. · TWSE:6541 | US$180.5M | US$225.7M | n/a | 11.3× | n/a | 1.2× | −222.8% | 0.4× | n/a |
| Korro Bio, Inc. · NASDAQ:KRRO | US$179.4M | US$74.36M | n/a | 57.6× | n/a | 2.0× | n/a | 0.0× | 1.46 |
| Median of the others | US$184.1M | US$110.8M | 37.6× | 1.3× | −223.8% | 0.0× | 1.34 |
Team and board
| Officer | Role |
|---|---|
| Ju Hee Kim | Chief Executive Officer |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 2.94B | 1.78B | 658.2M | 3.72B |
| Cost of revenue | 5.88B | 28.6M | 74.4M | 401.2M |
| Gross profit | -2.94B | 1.75B | 583.8M | 3.32B |
| Research and development | 19.5B | 16.2B | 12.2B | 11.0B |
| Selling, general and administrative | 2.05B | 1.34B | 1.57B | 1.21B |
| Operating income | -28.4B | -19.0B | -16.0B | -10.9B |
| Depreciation and amortization | 7.62B | 3.83B | 2.61B | 2.42B |
| EBITDA | -20.8B | -15.1B | -13.4B | -8.48B |
| Interest expense | 4.14B | 2.14B | 883.1M | 103.4M |
| Income before tax | -13.7B | -19.2B | -27.0B | -10.6B |
| Net income | -8.46B | -17.0B | -27.0B | -10.6B |
| Earnings per share, basic | -637.05 | -1,692.03 | -3,193.23 | -1,268.70 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 14.5B | 17.3B | 18.5B | 15.8B |
| Short-term investments | 11.3B | 23.0B | 3.13B | 8.04B |
| Receivables | 1.52B | 863.6M | 167.7M | 40.9M |
| Inventory | 887.6M | 10.1M | 45.7M | 131.4M |
| Current assets | 40.0B | 49.2B | 26.2B | 25.3B |
| Goodwill | 5.92B | |||
| Total assets | 110.6B | 72.3B | 45.2B | 34.9B |
| Accounts payable | 2.47B | |||
| Current liabilities | 19.8B | 11.0B | 28.9B | 2.61B |
| Long-term debt | 2.34B | 7.09B | 1.66B | |
| Total liabilities | 29.8B | 39.7B | 40.8B | 4.43B |
| Shareholders' equity | 64.5B | 32.6B | 4.41B | 30.4B |
| Shares outstanding | 13.3M | 10.0M | 8.45M | 8.35M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -20.3B | -13.8B | -11.7B | -5.19B |
| Capital spending | -7.26B | -4.22B | -7.14B | -1.98B |
| Free cash flow | -27.6B | -18.0B | -18.9B | -7.17B |
| Share buybacks | -3.88M | |||
| Change in cash | -2.80B | -1.22B | 2.70B | -3.48B |
Cap table
Built by 6ix from Inventage Lab, Inc.’s releases
- Common shares
- 13,307,708
- Fully diluted
- 13,307,708
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 13,307,708 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 13,307,708 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ju Hee Kim | Chief Executive Officer · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Inventage Lab, Inc.